Female condom launched in UK.
The lone-awaited female condom, Femidom, is to be launched at the end of September by manufacturers Chartex.  It is being welcomed by the FPA [Family Planning Association] and other family planning experts as a valuable addition to the existing range of contraceptive methods and as an alternative to the male condom in offering effective protection against sexually transmitted diseases including HIV.  A lubricated, loose-fitting polyurethane sheath, Femidom is inserted into the vagina at any time before sex.  An inner ring holds the condom in place beyond the pubic bone and an outer ring lies flat against the vulva.  In addition to extending choice, it is under direct control of the woman. As FPA Director Doreen Massey puts it:  "We have to face the fact that some women who want safer sex can't get their partners to use condoms. for the 1st time with Femidom, you can insist that if he won't use a condom, you'll use yours."  In trails of self-selected couples, up to 2/3 of women and their partners found the product acceptable.  a study at the Institute of Population Studies in Exeter showed that while some couples had initial misgivings about the condom's size and appearance, especially its visibility when in position, these often declined with repeated use.  Researcher Dr. Nicholas Ford pointed out that if the female condom makes a woman feel unattractive, her partner's comments may well influence these feelings.  Users' experience of insertion and the condom's comfort also improved with repeated use.  While there are no large studies showing ranges of effectiveness, it is likely to be as effective as the male condom (about 85%-98%).  In a study of 106 women at the margaret Pyke Center in London, there were 7 unplanned pregnancies:  4 were due to inconsistent use of the method and 3 were method failures.  Breakages were rare.  1/3 of participants dropped out in the 1st month.  Users should continue with their existing contraceptive method until they are sure that they are using Femidom efficiently, recommended the authors.  In October the FPA is launching a new free consumer leaflet on male and female condoms.  1/2 million leaflets will be distributed to UK pharmacies in October and November via the Pharmacy Healthcare Scheme as part of a safer sex campaign.  a launch event will include the results of a survey asking pharmacists and consumers what they think of condoms.
D001519:Behavior; D001723:Birth Rate; D017280:Condoms; D003267:Contraception; D003268:Contraception Behavior; D003710:Demography; D019049:Developed Countries; D005060:Europe; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D005298:Fertility; D010342:Patient Acceptance of Health Care; D011153:Population; D011157:Population Dynamics; D018873:Pregnancy Rate; D011584:Psychology; D006113:United Kingdom
Barrier Methods--women; Behavior; Condom--women; Contraception; Contraceptive Effectiveness; Contraceptive Methods--women; Contraceptive Usage; Demographic Factors; Developed Countries; Europe; Family Planning; Fertility; Fertility Measurements; Method Acceptability; Northern Europe; Population; Population Dynamics; Pregnancy Rate; Psychosocial Factors; United Kingdom; Use-effectiveness